MaxCyte, Inc. - Common Stock (NQ:MXCT)
Price and Volume
Detailed Quote| Volume | 3,787,224 |
| Open | 1.270 |
| Bid (Size) | 1.260 (500) |
| Ask (Size) | 1.290 (300) |
| Prev. Close | 1.250 |
| Today's Range | 1.255 - 1.310 |
| 52wk Range | 0.6434 - 1.865 |
| Shares Outstanding | 105,482,558 |
| Dividend Yield | N/A |
Top News
More NewsPerformance
52-Week Range
30.3% below 52-week high
1.300
0.6452W Low
1.8652W High
1 Week
2.3% below 1-week high
0.941W Low
1.331W High
MaxCyte, Inc. - Common Stock (MXCT) traded between $0.64 and $1.86 over the past 52 weeks and last traded at $1.30, 30.3% below its 52-week high. Over the past week it ranged between $0.94 and $1.33.
Past 12 Months
+27.5%
+10.6%
-8.5%
+53.8%
-16.1%
-21.2%
1W
+$0.28
1M
+$0.12
3M
-$0.12
6M
+$0.45
YTD
-$0.25
1Y
-$0.35
MXCT was -21.2% over the past year, +53.8% over six months, -16.1% year to date, +27.5% in the last week.
12 Months vs Market
MXCT
-21.2%
DIA
+12.6%
SPY
+16.5%
QQQ
+21.7%
IWM
+11.0%
Over the past 12 months MXCT returned -21.2% versus DIA (Dow) +12.6%, SPY (S&P 500) +16.5%, QQQ (Nasdaq 100) +21.7% and IWM (Russell 2000) +11.0%.
Volume & Liquidity
4.80× 3-mo avg
Today 3,787,224
3-mo avg 788.6K
1W
2.8M
1M
866.6K
3M
788.6K
6M
992.6K
YTD
1.0M
1Y
1.0M
MXCT most recently traded 3,787,224 shares against a 3-month average daily volume of 788.6K.
More News
Read More
MaxCyte Appoints Sidharth Kapileshwar as Chief Corporate Development Officer
September 23, 2026
From MaxCyte, Inc
Via GlobeNewswire
MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 11, 2026
From MaxCyte, Inc
Via GlobeNewswire
MaxCyte (MXCT) Q2 2026 Earnings Call Transcript ↗
August 19, 2026
Via The Motley Fool
Topics
Earnings
MaxCyte Q2 Earnings Call Highlights ↗
August 12, 2026
Via MarketBeat
Topics
Earnings
MaxCyte Reports Second Quarter 2026 Financial Results
August 12, 2026
From MaxCyte, Inc
Via GlobeNewswire
From MaxCyte, Inc
Via GlobeNewswire
Via Chartmill
MaxCyte Q1 Earnings Call Highlights ↗
May 12, 2026
Via MarketBeat
Topics
Earnings
From MaxCyte, Inc
Via GlobeNewswire
From MaxCyte, Inc
Via GlobeNewswire
MaxCyte (MXCT) Q4 2025 Earnings Call Transcript ↗
March 24, 2026
Via The Motley Fool
Topics
Earnings
MaxCyte Appoints Parmeet Ahuja as Chief Financial Officer
March 23, 2026
From MaxCyte, Inc
Via GlobeNewswire
MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery
February 24, 2026
From MaxCyte, Inc
Via GlobeNewswire
MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026
February 23, 2026
From MaxCyte, Inc
Via GlobeNewswire
Frequently Asked Questions
Is MaxCyte, Inc. - Common Stock publicly traded?
Yes, MaxCyte, Inc. - Common Stock is publicly traded.
What exchange does MaxCyte, Inc. - Common Stock trade on?
MaxCyte, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for MaxCyte, Inc. - Common Stock?
The ticker symbol for MaxCyte, Inc. - Common Stock is MXCT on the Nasdaq Stock Market
What is the current price of MaxCyte, Inc. - Common Stock?
The current price of MaxCyte, Inc. - Common Stock is 1.300
When was MaxCyte, Inc. - Common Stock last traded?
The last trade of MaxCyte, Inc. - Common Stock was at 10/15/26 04:00 PM ET
What is the market capitalization of MaxCyte, Inc. - Common Stock?
The market capitalization of MaxCyte, Inc. - Common Stock is 137.13M
How many shares of MaxCyte, Inc. - Common Stock are outstanding?
MaxCyte, Inc. - Common Stock has 137M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>